Mr. Speaker, I have a very brief question. I am sure the member has received a number of communications from constituents and from health network organizations. In my experience, from what I have seen and received so far, there seems to be a vibrant skepticism about the bill, both about what it does and about the process.
It will be helpful to the whole process if that skepticism is addressed frontally. In fact, this bill should pass at second reading and go to committee so that we can have public hearings and get the assurances and the explanations for all of the questions people have, because there are some allegations out there about what the bill does or does not do. It is not helpful when people have a misunderstanding.
I wonder if that has been the member's experience. Would she concur that we should ensure there are vibrant committee hearings on the bill to make sure we hear from the experts as well as the representatives of the users of natural health care products?